David Gaiero - May 10, 2024 Form 3 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Principal Financial Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
SNSE
Transactions as of
May 10, 2024
Transactions value $
$0
Form type
3
Date filed
5/16/2024, 04:55 PM
Previous filing
Mar 5, 2024
Next filing
Jun 10, 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24 - Power of Attorney